Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1996;23(1):36–41.

Current status of anticoagulation and thrombosis-related issues in mechanical valves.

R J Gray 1
PMCID: PMC325300  PMID: 8680272

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman R., Rouvier J., Gurfinkel E., D'Ortencio O., Manzanel R., de La Fuente L., Favaloro R. G. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1991 Mar;101(3):427–431. [PubMed] [Google Scholar]
  2. Beaudet R. L., Poirier N. L., Doyle D., Nakhlé G., Gauvin C. The Medtronic-Hall cardiac valve: 7 1/2 years' clinical experience. Ann Thorac Surg. 1986 Dec;42(6):644–650. doi: 10.1016/s0003-4975(10)64598-5. [DOI] [PubMed] [Google Scholar]
  3. Björk V. O., Henze A. Ten years' experience with the Björk-Shiley tilting disc valve. J Thorac Cardiovasc Surg. 1979 Sep;78(3):331–342. [PubMed] [Google Scholar]
  4. Bussey H. I., Force R. W., Bianco T. M., Leonard A. D. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med. 1992 Feb;152(2):278–282. [PubMed] [Google Scholar]
  5. Chesebro J. H., Fuster V., Elveback L. R., McGoon D. C., Pluth J. R., Puga F. J., Wallace R. B., Danielson G. K., Orszulak T. A., Piehler J. M. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol. 1983 May 15;51(9):1537–1541. doi: 10.1016/0002-9149(83)90673-2. [DOI] [PubMed] [Google Scholar]
  6. Copans H., Lakier J. B., Kinsley R. H., Colsen P. R., Fritz V. U., Barlow J. B. Thrombosed Björk-Shiley mitral prostheses. Circulation. 1980 Jan;61(1):169–174. doi: 10.1161/01.cir.61.1.169. [DOI] [PubMed] [Google Scholar]
  7. Cortina J. M., Martinell J., Artiz V., Fraile J., Rábago G. Comparative clinical results with Omniscience (STM1), Medtronic-Hall, and Björk-Shiley convexo-concave (70 degrees) prostheses in mitral valve replacement. J Thorac Cardiovasc Surg. 1986 Feb;91(2):174–183. [PubMed] [Google Scholar]
  8. Deviri E., Sareli P., Wisenbaugh T., Cronje S. L. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol. 1991 Mar 1;17(3):646–650. doi: 10.1016/s0735-1097(10)80178-0. [DOI] [PubMed] [Google Scholar]
  9. DiSesa V. J., Collins J. J., Jr, Cohn L. H. Hematological complications with the St. Jude valve and reduced-dose Coumadin. Ann Thorac Surg. 1989 Aug;48(2):280–283. doi: 10.1016/0003-4975(89)90089-1. [DOI] [PubMed] [Google Scholar]
  10. Eberlein U., von der Emde J., Rein J., Esperer H. D. Thromboembolic and bleeding complications after mitral valve replacement. Eur J Cardiothorac Surg. 1990;4(11):605–612. doi: 10.1016/1010-7940(90)90020-z. [DOI] [PubMed] [Google Scholar]
  11. Harada Y., Imai Y., Kurosawa H., Ishihara K., Kawada M., Fukuchi S. Ten-year follow-up after valve replacement with the St. Jude Medical prosthesis in children. J Thorac Cardiovasc Surg. 1990 Aug;100(2):175–180. [PubMed] [Google Scholar]
  12. Hartz R. S., LoCicero J., 3rd, Kucich V., DeBoer A., O'Mara S., Meyers S. N., Michaelis L. L. Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position. J Thorac Cardiovasc Surg. 1986 Oct;92(4):684–690. [PubMed] [Google Scholar]
  13. Hirsh J., Dalen J. E., Deykin D., Poller L. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1992 Oct;102(4 Suppl):312S–326S. doi: 10.1378/chest.102.4.312s. [DOI] [PubMed] [Google Scholar]
  14. Horstkotte D., Schulte H., Bircks W., Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis. 1993 May;2(3):291–301. [PubMed] [Google Scholar]
  15. Husebye D. G., Pluth J. R., Piehler J. M., Schaff H. V., Orszulak T. A., Puga F. J., Danielson G. K. Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients. J Thorac Cardiovasc Surg. 1983 Oct;86(4):543–552. [PubMed] [Google Scholar]
  16. Ledain L. D., Ohayon J. P., Colle J. P., Lorient-Roudaut F. M., Roudaut R. P., Besse P. M. Acute thrombotic obstruction with disc valve prostheses: diagnostic considerations and fibrinolytic treatment. J Am Coll Cardiol. 1986 Apr;7(4):743–751. doi: 10.1016/s0735-1097(86)80331-x. [DOI] [PubMed] [Google Scholar]
  17. Martinell J., Fraile J., Artiz V., Cortina J., Fresneda P., Rábago G. Reoperations for left-sided low-profile mechanical prosthetic obstructions. Ann Thorac Surg. 1987 Feb;43(2):172–175. doi: 10.1016/s0003-4975(10)60390-6. [DOI] [PubMed] [Google Scholar]
  18. Sade R. M., Crawford F. A., Jr, Fyfe D. A., Stroud M. R. Valve prostheses in children: a reassessment of anticoagulation. J Thorac Cardiovasc Surg. 1988 Apr;95(4):553–561. [PubMed] [Google Scholar]
  19. Saour J. N., Sieck J. O., Mamo L. A., Gallus A. S. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med. 1990 Feb 15;322(7):428–432. doi: 10.1056/NEJM199002153220703. [DOI] [PubMed] [Google Scholar]
  20. Schaffer M. S., Clarke D. R., Campbell D. N., Madigan C. K., Wiggins J. W., Jr, Wolfe R. R. The St. Jude Medical cardiac valve in infants and children: role of anticoagulant therapy. J Am Coll Cardiol. 1987 Jan;9(1):235–239. doi: 10.1016/s0735-1097(87)80108-0. [DOI] [PubMed] [Google Scholar]
  21. Sethia B., Turner M. A., Lewis S., Rodger R. A., Bain W. H. Fourteen years' experience with the Björk-Shiley tilting disc prosthesis. J Thorac Cardiovasc Surg. 1986 Mar;91(3):350–361. [PubMed] [Google Scholar]
  22. Silber H., Khan S. S., Matloff J. M., Chaux A., DeRobertis M., Gray R. The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation. 1993 Jan;87(1):30–37. doi: 10.1161/01.cir.87.1.30. [DOI] [PubMed] [Google Scholar]
  23. Spencer F. C., Trinkle J. K., Reeves J. T. Successful replacement of a thrombosed mitral ball-valve prosthesis. JAMA. 1965 Dec 13;194(11):1249–1251. [PubMed] [Google Scholar]
  24. Turpie A. G., Gent M., Laupacis A., Latour Y., Gunstensen J., Basile F., Klimek M., Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993 Aug 19;329(8):524–529. doi: 10.1056/NEJM199308193290802. [DOI] [PubMed] [Google Scholar]
  25. Vallejo J. L., Gonzalez-Santos J. M., Albertos J., Riesgo M. J., Bastida M. E., Rico M. J., Gonzalez-Diego F., Arcas R. Eight years' experience with the Medtronic-Hall valve prosthesis. Ann Thorac Surg. 1990 Sep;50(3):429–436. doi: 10.1016/0003-4975(90)90489-s. [DOI] [PubMed] [Google Scholar]
  26. Vogt S., Hoffmann A., Roth J., Dubach P., Bertschmann W., Hasse J., Grädel E., Stulz P., Burckhardt D. Heart valve replacement with the Björk-Shiley and St Jude Medical prostheses: a randomized comparison in 178 patients. Eur Heart J. 1990 Jul;11(7):583–591. doi: 10.1093/oxfordjournals.eurheartj.a059763. [DOI] [PubMed] [Google Scholar]
  27. Wilson D. B., Dunn M. I., Hassanein K. Low-intensity anticoagulation in mechanical cardiac prosthetic valves. Chest. 1991 Dec;100(6):1553–1557. doi: 10.1378/chest.100.6.1553. [DOI] [PubMed] [Google Scholar]
  28. Witchitz S., Veyrat C., Moisson P., Scheinman N., Rozenstajn L. Fibrinolytic treatment of thrombus on prosthetic heart valves. Br Heart J. 1980 Nov;44(5):545–554. doi: 10.1136/hrt.44.5.545. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES